Table 1.
Cases used for enrichment of soluble and PHF-tau.
| Case # | Gender | Age | Braak stage |
|---|---|---|---|
| BB98-003 | M | 75 | - |
| BB00-002 | M | 69 | - |
| 15196262 | M | 81 | I |
| 15115927 | M | 77 | I |
| 11072071 | M | 88 | II |
| 20610726 | F | 87 | III |
| 20800682 | F | 84 | III |
| 09740777 | M | 77 | V |
| 62749390 | F | 84 | V |
| 73257978 | F | 87 | V |
| 98939847 | M | 81 | VI |
Seven non-demented, aged-matched controls (Braak stages I-III), and four severe AD cases (Braak stages V and VI) were used to determine the presence of tau nitrated at Tyr 18 within soluble and insoluble (PHF) tau preparations.